Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.
Makhoul I, Todorova VK, Siegel ER, Erickson SW, Dhakal I, Raj VR, Lee JY, Orloff MS, Griffin RJ, Henry-Tillman RS, Klimberg S, Hutchins LF, Kadlubar SA. Makhoul I, et al. Among authors: hutchins lf. PLoS One. 2017 Jan 3;12(1):e0168550. doi: 10.1371/journal.pone.0168550. eCollection 2017. PLoS One. 2017. PMID: 28045923 Free PMC article.
Breast cancer.
Hutchins LF, Broadwater R Jr, Lang NP, Maners A, Bowie M, Westbrook KC. Hutchins LF, et al. Dis Mon. 1990 Feb;36(2):63-125. doi: 10.1016/0011-5029(90)90002-9. Dis Mon. 1990. PMID: 2406115 Review.
Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Kass R, Bellone S, Palmieri M, Canè S, Bignotti E, Henry-Tillman R, Hutchins L, Cannon MJ, Klimberg S, Santin AD. Kass R, et al. Breast Cancer Res Treat. 2003 Aug;80(3):275-85. doi: 10.1023/A:1024938215782. Breast Cancer Res Treat. 2003. PMID: 14503800
Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey S, Nakagawa M, Rosenbaum ER, Arnaoutakis K, Hutchins LF, Makhoul I, Milojkovic N, Cottler-Fox M. Pandey S, et al. Among authors: hutchins lf. J Clin Apher. 2015 Feb;30(1):50-4. doi: 10.1002/jca.21348. Epub 2014 Jul 17. J Clin Apher. 2015. PMID: 25042026
Moving a Carbohydrate Mimetic Peptide into the clinic.
Makhoul I, Hutchins L, Emanuel PD, Pennisi A, Siegel E, Jousheghany F, Monzavi-Karbassi B, Kieber-Emmons T. Makhoul I, et al. Hum Vaccin Immunother. 2015;11(1):37-44. doi: 10.4161/hv.34300. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483513 Free PMC article. Clinical Trial.
117 results